Published Studies Related to Lidoderm (Lidocaine Patch)
Treatment for postoperative wound pain in gynecologic laparoscopic surgery:
topical lidocaine patches. 
CONCLUSIONS: Topical lidocaine patches at the laparoscopic port sites reduced
Lidocaine/tetracaine patch (Rapydan) for topical anaesthesia before arterial
access: a double-blind, randomized trial. 
non-inferior to subcutaneous local anaesthetic... CONCLUSIONS: Both the lidocaine/tetracaine patch and subcutaneous injection of
Effects of lidocaine patch on intradermal capsaicin-induced pain: a double-blind, controlled trial. [2011.03]
This study evaluated the effects of topical lidocaine on skin sensation and on intradermal capsaicin-induced pain and hyperalgesia. A randomized, double-blinded, placebo controlled methodology was used...
Effects of lidocaine patch on intradermal capsaicin-induced pain: a double-blind,
controlled trial. 
This study evaluated the effects of topical lidocaine on skin sensation and on
intradermal capsaicin-induced pain and hyperalgesia. A randomized,
double-blinded, placebo controlled methodology was used...
Lidocaine/tetracaine medicated plaster: in minor dermatological and needle puncture procedures. [2010.11.12]
The lidocaine/tetracaine medicated plaster comprises a lidocaine/tetracaine 70 mg/70 mg patch and a controlled heat-assisted drug delivery pod that increases the diffusion of lidocaine and tetracaine into the dermis. Following a 1-hour application period, systemic absorption of lidocaine or tetracaine from the plaster was minimal...
Clinical Trials Related to Lidoderm (Lidocaine Patch)
Tumescent Lidocaine Maximum Safe mg/kg Dosage [Enrolling by invitation]
This pharmacokinetic clinical trial is a dose ranging study of lidocaine in tumescent local
anesthesia. The goal is to understand the absorption pharmacokinetic of tumescent lidocaine
and to determine an objective (statistical) estimate of the maximum safe mg/kg dosage of
lidocaine in tumescent local anesthesia without liposuction.
Pilot Study of the Efficacy and Safety of Lidoderm Patch in the Treatment of Low Back Pain [Completed]
Patients with moderate to severe chronic Low Back Pain (LBP) despite current analgesic
treatment participated in a Phase IV clinical trial to evaluate the analgesic efficacy of
the lidocaine patch 5% compared to placebo in treating moderate to severe chronic LBP.
A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions [Completed]
Patients with postherpetic neuralgia (PHN), diabetic neuropathy (DN), complex regional pain
syndrome (CRPS), carpal tunnel syndrome, HIV neuropathy, idiopathic sensory neuropathy, or
other peripheral neuropathy participated in a Phase IV clinical trial to assess the
comparative efficacy and safety of Lidoderm monotherapy versus gabapentin monotherapy in
treating a diverse group of peripheral neuropathic pain patients.
Efficacy and Safety of the Lidoderm Patch Applied to Patients With Osteoarthritis of the Knee [Completed]
Patients with knee pain due to Osteoarthritis (OA) experiencing sub-optimal pain relief from
their current analgesic regimen will participate in a pilot clinical trial to evaluate the
effectiveness and tolerability of the Lidoderm Patch compared with placebo in treating knee
pain from OA.
Lidocaine Infusion as a Treatment for Cocaine Relapse and Craving [Recruiting]
We propose that the systemic administration of lidocaine following the induction of
cue-induced craving, relative to saline plus cue-induced craving or lidocaine without
cue-induced craving, will block the reconsolidation of cue memories. This will lead to a
reduction in cue-induced craving upon repeated testing as well as subsequent cocaine use and
Reports of Suspected Lidoderm (Lidocaine Patch) Side Effects
Drug Ineffective (7),
Muscular Weakness (6),
Oedema Peripheral (5),
Drug Hypersensitivity (4),
Weight Decreased (3),
Constipation (3), more >>